Andrea De Rosa

No ORCID on file · 1 paper in corpus

observational 2026

Clinical use of recombinant human luteinizing hormone beyond hypogonadotropic hypogonadism: a multicenter descriptive analysis from five Italian fertility centers

Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-026-01551-y

BACKGROUND: Recombinant human luteinizing hormone (rLH) was originally introduced to supplement recombinant human follicle-stimulating hormone (rFSH) for controlled ovarian stimulation (COS) in patients with hypogonadotropic hypogonadism. P…